feed,title,long_url,short_url
Motley,Is Novo Nordisk a Buy After Its New Obesity Candidate's Success in a Clinical Trial?,https://www.fool.com/investing/2024/03/10/is-novo-nordisk-a-buy-after-its-new-obesity-candid/?source=iedfolrf0000001,https://da.gd/u9PVS
